相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer
Ming Zhao et al.
CANCER SCIENCE (2012)
The Impact of the Activated Stroma on Pancreatic Ductal Adenocarcinoma Biology and Therapy Resistance
Mert Erkan et al.
CURRENT MOLECULAR MEDICINE (2012)
Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology
Pawel K. Mazur et al.
GUT (2012)
Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine
Toshio Fujisawa et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer
Sean P. Dineen et al.
CANCER RESEARCH (2010)
Triptolide and TRAIL Combination Enhances Apoptosis in Cholangiocarcinoma
Kimberly A. Clawson et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer
Savita Bisht et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
Mallika Singh et al.
NATURE BIOTECHNOLOGY (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Michael P. Kim et al.
NATURE PROTOCOLS (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo
Mara B. Antonoff et al.
SURGERY (2009)
The role of the tumor microenvironment in the progression of pancreatic cancer
Buckminster Farrow et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70
Phoebe A. Phillips et al.
CANCER RESEARCH (2007)
Pancreatic cancer microenvironment
Joerg Kleeff et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Synergistic activity of troxacitabine (Troxatyl ™) and gemcitabine in pancreatic cancer
Vijaya L. Damaraju et al.
BMC CANCER (2007)
Stromal biology of pancreatic cancer
Gerald C. Chu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma
Ali Aghdassi et al.
CANCER RESEARCH (2007)
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Daruka Mahadevan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo
Leo Christopher DeRosier et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Genetically engineered models have advantages over xenografts for preclinical studies
OJ Becher et al.
CANCER RESEARCH (2006)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)